Annals of Neurology · 1996 · 119 citations · 29 references
Life SciencesGeneticsMolecular GeneticsMolecular NeuroscienceNeurodegenerationNeurogeneticsAlzheimer DiseaseDementia Risk FactorsMolecular Basis Of NeurodegenerationNeurodegenerative Disease GeneticsNeurodegenerative DiseasesNeurodegenerative DisordersAlpha-synuclein Gene VariantsAmyloid Beta PeptidesAmyloid FibrillogenesisAmyloid PolymorphismApolipoprotein E Genotype RiskGenetic Marker AssociationNeurodegeneration GeneticsNeurodegenerative Genetics
The non-Abeta component of Alzheimer's disease amyloid (NAC) is copurified with amyloid from the brain tissue of Alzheimer's disease victims and is immunohistochemically localized to amyloid fibrils. NAC is a hydrophobic peptide fragment from the NAC precursor protein (NACP/alpha-synuclein) that is localized to presynaptic terminals. We used a polymorphic dinucleotide repeat sequence in a genomic clone of NACP for genetic association and linkage studies. Screening of Alzheimer's disease families failed to establish linkage between NACP and Alzheimer's disease. Nevertheless, one of the NACP polymorphisms (NACP allele 2) was shown to have significant association with healthy elderly control individuals with apolipoprotein E risk. This may indicate a possible protective function of the allele.
29
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 28K citations · Full text
Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel et al. · Proceedings of the National Academy of Sciences · 1993 · 4.3K citations · Full text
Life Sciences, Genetics, Neurology +17